Teva Pharmaceutical Industries Ltd- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Teva Pharmaceutical Industries Ltd 公司

Teva Pharmaceutical Industries Ltd 是一家总部位于以色列的制药公司。该公司通过三个部门运营：北美、欧洲和国际市场。每个业务部门管理其所在地区的整个产品组合，包括仿制药、特种产品和非处方 (OTC) 产品。除了这三个部门之外，该公司还开展其他业务，主要是向第三方销售活性药物成分 (API)、某些合同制造服务以及通过其附属公司 Medis 向其他制药公司提供产品组合的对外授权平台。

Teva Pharmaceutical Industries Ltd简介



公司代码TEVA

公司名称Teva Pharmaceutical Industries Ltd

上市日期Jan 01, 1951

CEOMr. Richard D. Francis

员工数量33892

证券类型Ordinary Share

年结日Jan 01

公司地址124 Dvora Hanevi'a St.

城市TEL AVIV-YAFO

上市交易所Tel Aviv Stock Exchange

国家Israel

邮编6944020

电话97239148213

网址https://www.tevapharm.com/

公司代码TEVA

上市日期Jan 01, 1951

CEOMr. Richard D. Francis

Teva Pharmaceutical Industries Ltd公司高管



名称

名称/职务

职务

持股

持股变动

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

13.03K

+9.34%

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

Mr. Eliyahu Sharon (Eli) Kalif

Chief Financial Officer, Executive Vice President

--

Mr. Matthew Shields

Executive Vice President - Teva Global Operations

--

Mr. Chen Lichtenstein

Independent Director

--

Dr. Sol J. Barer, Ph.D.

Independent Chairman of the Board

--

名称

名称/职务

职务

持股

持股变动

Prof. Varda Shalev

Independent Director

22.50K

+74.83%

Ms. Christine (Chris) Fox

Executive Vice President - U.S. Commercial

14.28K

--

Mr. David R. McAvoy

Executive Vice President, Chief Legal Officer

13.03K

+9.34%

Mr. Evan Lippman

Executive Vice President - Business Development

--

Mr. Placid Jover

Executive Vice President, Chief Human Resources Officer

--

Mr. Richard Daniell

Executive Vice President - European Commercial

--

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Generic products

2.41B

57.73%

AUSTEDO

498.00M

11.93%

Anda

365.00M

8.74%

Other

247.00M

5.91%

AJOVY

154.00M

3.69%

其他

501.00M

12.00%

地区USD

名称

营收

占比

United States

2.15B

51.51%

Europe

1.30B

31.06%

International Markets

495.00M

11.85%

Other

232.00M

5.56%

业务

地区

业务USD

名称

营收

占比

Generic products

2.41B

57.73%

AUSTEDO

498.00M

11.93%

Anda

365.00M

8.74%

Other

247.00M

5.91%

AJOVY

154.00M

3.69%

其他

501.00M

12.00%

股东统计

更新时间: 11月4日周二

持股股东

股东类型

持股股东

占比

Menora Mivtachim Insurance Ltd.

5.00%

Fidelity Management & Research Company LLC

4.41%

Phoenix Investment and Finances Ltd

3.60%

Ion Asset Management Israel Ltd

3.34%

Harel Insurance Investments and Financial Services Ltd

3.29%

其他

80.35%

持股股东

占比

Menora Mivtachim Insurance Ltd.

5.00%

Fidelity Management & Research Company LLC

4.41%

Phoenix Investment and Finances Ltd

3.60%

Ion Asset Management Israel Ltd

3.34%

Harel Insurance Investments and Financial Services Ltd

3.29%

其他

80.35%

股东类型

持股股东

占比

Investment Advisor

25.80%

Hedge Fund

13.29%

Investment Advisor/Hedge Fund

11.28%

Insurance Company

7.85%

Research Firm

2.46%

Pension Fund

1.90%

Family Office

1.42%

Bank and Trust

0.90%

Sovereign Wealth Fund

0.24%

其他

34.85%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1124

742.23M

64.70%

-84.92M

2025Q2

1100

749.18M

65.31%

-13.97M

2025Q1

1130

727.69M

63.46%

-282.41K

2024Q4

1087

683.52M

59.66%

-22.86M

2024Q3

1029

663.95M

58.60%

-6.13M

2024Q2

1002

631.05M

55.72%

-26.20M

2024Q1

950

595.83M

53.15%

-34.73M

2023Q4

932

601.27M

53.63%

+7.51M

2023Q3

929

573.53M

51.16%

-84.22M

2023Q2

921

512.98M

45.79%

-122.32M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Menora Mivtachim Insurance Ltd.

57.40M

5%

+18.90M

+49.10%

Jul 16, 2025

Fidelity Management & Research Company LLC

50.63M

4.41%

-24.67M

-32.76%

Jun 30, 2025

Phoenix Investment and Finances Ltd

37.76M

3.29%

+10.30M

+37.49%

Jun 30, 2025

Ion Asset Management Israel Ltd

38.35M

3.34%

-685.63K

-1.76%

Jun 30, 2025

Harel Insurance Investments and Financial Services Ltd

33.39M

2.91%

+11.33M

+51.39%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

33.89M

2.95%

+833.03K

+2.52%

Jun 30, 2025

Migdal Insurance and Financial Holdings Ltd

28.69M

2.5%

+2.35M

+8.92%

Jun 30, 2025

Clal Insurance Enterprises Holdings Ltd.

32.36M

2.82%

-5.43M

-14.37%

Jun 30, 2025

Lingotto Investment Management LLP

28.16M

2.45%

+302.98K

+1.09%

Jun 30, 2025

Rubric Capital Management LP

26.00M

2.27%

+450.00K

+1.76%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

VanEck Israel ETF

7.07%

iShares MSCI Israel ETF

6.66%

ARK Israel Innovative Technology ETF

1.9%

VanEck Pharmaceutical ETF

1.73%

WealthTrust DBS Long Term Growth ETF

1.36%

WisdomTree International Multifactor Fund

0.59%

iShares Health Innovation Active ETF

0.5%

iShares MSCI Intl Value Factor ETF

0.41%

iShares MSCI EAFE Value ETF

0.14%

DFA Dimensional Internatl High Profitability ETF

0.12%

VanEck Israel ETF

占比7.07%

iShares MSCI Israel ETF

占比6.66%

ARK Israel Innovative Technology ETF

占比1.9%

VanEck Pharmaceutical ETF

占比1.73%

WealthTrust DBS Long Term Growth ETF

占比1.36%

WisdomTree International Multifactor Fund

占比0.59%

iShares Health Innovation Active ETF

占比0.5%

iShares MSCI Intl Value Factor ETF

占比0.41%

iShares MSCI EAFE Value ETF

占比0.14%

DFA Dimensional Internatl High Profitability ETF

占比0.12%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据